Literature DB >> 10415373

Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia.

N Hosomi1, K Mizushige, M Kitadai, H Ohyama, S I Ichihara, T Takahashi, H Matsuo.   

Abstract

The effect of induced hypertension treatment on cerebral ischemia is still controversial. We investigated the preferred blood pressure manipulation level and pressor agent required to reduce cerebral ischemic injury following transient forebrain ischemia induced by bilateral occlusion of the common carotid arteries in anesthetized gerbils. Following 60-min cerebral ischemia, we evaluated the preferred blood pressure manipulation level and pressor agent required to treat cerebral ischemic injury after reperfusion by examining the effects of different levels of mean arterial blood pressure (MABP), increased with phenylephrine or angiotensin II or decreased by blood withdrawal, on cerebral blood flow (CBF), survival ratio, cerebral edema, and brain energy metabolism following transient forebrain ischemia in gerbils. Mild phenylephrine-induced hypertension treatment (21+/-4 mmHg) during post-cerebral ischemia-reperfusion improved the survival ratio and reduced cerebral edema, which was also associated with an increase in local CBF and a recovery of brain energy metabolism. However, intense phenylephrine-induced hypertension, angiotensin II-induced hypertension, or hypotension worsen the survival rate and produced extra cerebral edema, that were also associated with deterioration of brain energy metabolism. These results demonstrate that a mild induced hypertension with phenylephrine (21+/-4 mmHg above the baseline level) results in reduction of the cerebral edema and improves the survival ratio and brain energy metabolism. Furthermore, angiotensin II may have neurotoxic effect to use as the pressor agent for induced hypertension after cerebral ischemia. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415373     DOI: 10.1016/s0006-8993(99)01577-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Ameliorating effects of Kangen-karyu on neuronal damage in rats subjected to repeated cerebral ischemia.

Authors:  Fengling Pu; Tomohiro Kaneko; Makiko Enoki; Keiichi Irie; Takuya Okamoto; Yasuo Sei; Nobuaki Egashira; Ryozo Oishi; Kenichi Mishima; Hidetoshi Kamimura; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  J Nat Med       Date:  2010-02-13       Impact factor: 2.343

3.  Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.

Authors:  Vaibhav Gaur; Anil Kumar
Journal:  Inflammopharmacology       Date:  2011-08       Impact factor: 4.473

4.  Mmp-9, a potential target for cerebral ischemic treatment.

Authors:  Xue Dong; Yu-Ning Song; Wei-Guo Liu; Xiu-Li Guo
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  Monitoring Pressure Augmentation in Patients With Ischemic Penumbra Using Continuous Electroencephalogram: Three Cases and a Review of the Literature.

Authors:  Christopher R Newey; Vikas Gupta; Agnieszka A Ardelt
Journal:  Neurohospitalist       Date:  2017-05-11

6.  Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.

Authors:  Hamdollah Panahpour; Ali Akbar Nekooeian; Gholam Abbas Dehghani
Journal:  Iran Biomed J       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.